Aspira Women's Health Inc., together with its subsidiaries, engages in developing and commercializing diagnostic tests for gynecologic disease in the United States. The company provides OVA1, OVERA, and OVA1plus to detect risk of ovarian malignancy in women with adnexal masses. It also offers ASPiRA GenetiX, a genetic test for the risk of gynecologic cancer. In addition, the company operates Aspira Synergy, a testing platform and cloud service for decentralized access of protein biomarker and hereditary genetic testing; and owns and operates …
Over the last 12 months, insiders at Aspira Women's Health Inc. have bought $142,935 and sold $0 worth of Aspira Women's Health Inc. stock.
On average, over the past 5 years, insiders at Aspira Women's Health Inc. have bought $2.25M and sold $71,151 worth of stock each year.
Highest buying activity among insiders over the last 12 months: SCHULER JACK W (10 percent owner) — $658,500. Sandford Nicole (President & CEO) — $33,185.
The last purchase of 6,536 shares for transaction amount of $10,000 was made by SCHULER JACK W (10 percent owner) on 2024‑07‑09.
2024-07-09 | 10 percent owner | 6,536 0.0674% | $1.53 | $10,000 | -25.00% | |||
2024-05-31 | Chief Executive Officer | 9,493 0.1549% | $2.42 | $22,973 | -61.13% | |||
2024-01-26 | 10 percent owner | 28,500 0.6724% | $3.50 | $99,750 | -72.97% | |||
2024-01-26 | President & CEO | 2,400 0.0688% | $4.25 | $10,212 | -72.97% | |||
2023-12-06 | Sale | Secretary & General Counsel | 980 0.0223% | $3.37 | $3,303 | -38.36% | ||
2023-12-06 | President & CEO | 5,000 0.1133% | $3.36 | $16,800 | -38.36% | |||
2023-09-08 | Chief Financial Officer | 2,246 0.0651% | $4.30 | $9,658 | -18.52% | |||
2023-07-24 | 10 percent owner | 181,800 3.3703% | $2.75 | $499,950 | +41.43% | |||
2023-07-24 | President & CEO | 12,563 0.3371% | $3.98 | $50,001 | +41.43% | |||
2023-07-24 | director | 6,281 0.1685% | $3.98 | $24,998 | +41.43% | |||
2023-07-24 | director | 3,769 0.1011% | $3.98 | $15,001 | +41.43% | |||
2023-07-24 | director | 3,769 0.1011% | $3.98 | $15,001 | +41.43% | |||
2023-07-24 | director | 6,281 0.1685% | $3.98 | $24,998 | +41.43% | |||
2023-07-24 | director | 8,794 0.2359% | $3.98 | $35,000 | +41.43% | |||
2023-07-24 | director | 754 0.0202% | $3.98 | $3,001 | +41.43% | |||
2023-07-24 | CSO & COO | 628 0.0168% | $3.98 | $2,499 | +41.43% | |||
2023-07-24 | General counsel and secretary | 754 0.0202% | $3.98 | $3,001 | +41.43% | |||
2023-07-24 | Chief Financial Officer | 754 0.0202% | $3.98 | $3,001 | +41.43% | |||
2022-08-25 | 266,666 0.6741% | $0.38 | $100,000 | -26.00% | ||||
2022-08-25 | 13,332 – | $0 | $0 | -26.00% |
Sandford Nicole | Chief Executive Officer | 70596 0.4236% | $0.77 | 5 | 0 | +1.54% |
SCHULER JACK W | 10 percent owner | 6536 0.0392% | $0.77 | 19 | 0 | <0.0001% |
FEINBERG LARRY N | 10 percent owner | 9825289 58.9495% | $0.77 | 3 | 0 | <0.0001% |
Schuler Henri George | 10 percent owner | 6047057 36.281% | $0.77 | 16 | 2 | +5.15% |
RATHMANN JAMES L | director | 4391877 26.3503% | $0.77 | 2 | 0 |